02141nam a2200373Ia 4500001001200000003000600012005001700018007001400035008004100049020001500090020001800105040005600123043001200179074001600191086002900207110016800236245021500404260008500619300002800704336000800732337001600740338001900756490002300775500003600798500002500834533009900859776022600958776024201184810006001426650007001486650007801556650008501634650004801719ocm67838874OCoLC20180723122403.0he bmb024bbca060428s2006    dcu     b    f000 0 eng d  a0160757258  a9780160757259  aPUCPRbengcANGdOCLCOdOCLCQdOCLCFdGPOdMvIerda  an-us---  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.109-2491 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aStem cells research, 2005 :bhearing before a Subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, first session, special hearing, October 19, 2005, Washington, DC.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O.,c2006.  aiii, 25 pages ;c24 cm.  btxt  bh2rdamedia  bhe2rdacarrier1 aS. hrg. ;v109-249  aShipping list no.: 2006-0117-M.  aCRDP Program record.  aMicrofiche.b[Washington, DC] :cSupt. of Docs., U.S. G.P.O.,d2006.e1 microfiche : negative.08iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tStem cells research, 2005w(OCoLC)68208559908iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tStem cells research, 2005w(DLC) 2006415412w(OCoLC)645818351 aUnited States.bCongress.bSenate.tS. hrg. ;v109-249. 0aEmbryonic stem cellsxResearchxGovernment policyzUnited States. 0aEmbryonic stem cellsxResearchxMoral and ethical aspectszUnited States. 0aEmbryonic stem cellsxTransplantationxMoral and ethical aspectszUnited States. 0aCancerxTreatmentxResearchzUnited States.